Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Ponticelli

Transplantation

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Transplantation|November 13, 2023
Autophagy: A Silent Protagonist in Kidney TransplantationClaudio Ponticelli, Francesco Reggiani, Gabriella Moroni
Transplantation|December 13, 2005
The clinical impact of chronic transplant glomerulopathy in cyclosporine eraGiovanni Banfi, Margarita Villa, Donata Cresseri, et al.
Transplantation|November 19, 2004
Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label studyBjörn Nashan, John Curtis, Claudio Ponticelli, et al.
Transplantation|January 24, 2008
Risk factors for cardiovascular events after successful renal transplantationYves F C Vanrenterghem, Kathleen Claes, Giuseppe Montagnino, et al.
Transplantation|September 17, 2004
Is cyclosporine in renal-transplant recipients more effective when given twice a day than in a single daily dose?Antonio Tarantino, Patrizia Passerini, Mariarosaria Campise, et al.
Transplantation|December 6, 2003
Oxidative stress in kidney transplant patientsMariarosaria Campise, Fabrizia Bamonti, Cristina Novembrino, et al.
Transplantation|May 10, 2005
Natural history of hepatitis B and C in renal allograft recipientsAdriana Aroldi, Pietro Lampertico, Giuseppe Montagnino, et al.
Transplantation|November 26, 2009
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trialMaurizio Salvadori, Maria Piera Scolari, Elisabetta Bertoni, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Transplantation|November 13, 2023
Autophagy: A Silent Protagonist in Kidney TransplantationClaudio Ponticelli, Francesco Reggiani, Gabriella Moroni
Transplantation|December 13, 2005
The clinical impact of chronic transplant glomerulopathy in cyclosporine eraGiovanni Banfi, Margarita Villa, Donata Cresseri, et al.
Transplantation|November 19, 2004
Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label studyBjörn Nashan, John Curtis, Claudio Ponticelli, et al.
Transplantation|January 24, 2008
Risk factors for cardiovascular events after successful renal transplantationYves F C Vanrenterghem, Kathleen Claes, Giuseppe Montagnino, et al.
Transplantation|September 17, 2004
Is cyclosporine in renal-transplant recipients more effective when given twice a day than in a single daily dose?Antonio Tarantino, Patrizia Passerini, Mariarosaria Campise, et al.
Transplantation|December 6, 2003
Oxidative stress in kidney transplant patientsMariarosaria Campise, Fabrizia Bamonti, Cristina Novembrino, et al.
Transplantation|May 10, 2005
Natural history of hepatitis B and C in renal allograft recipientsAdriana Aroldi, Pietro Lampertico, Giuseppe Montagnino, et al.
Transplantation|November 26, 2009
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trialMaurizio Salvadori, Maria Piera Scolari, Elisabetta Bertoni, et al.
Pageof 1